The company's BoneScalpel with ultrasonic technology has been designed for spine surgeons to make precise and safe bone cuts during challenging spine surgeries.

BoneScalpel can be used in deformity cases, as well as laminectomies and transforaminal lumbar interbody fusion (TLIF) procedures.

SonaStar is an advanced ultrasonic surgical aspiration system, which can be used in precise soft tissue aspiration and removal of fibrous and osseous structures as required.

In April this year, the frim launched new SonicVac vaccum assisted ultrasonic wound debriment technology to treat chronic wounds.

Misonix global sales and marketing senior vice presidentScott Ludecker said:"The CNS Meeting is an important meeting for Misonix as we look to further expand our commercial footprint in the neurosurgery community and more broadly introduce our ultrasound technologies."

“I am pleased to see that a substantial number of neurosurgeons who visited with our onsite team in the exhibit have already requested system evaluations at their respective institutions.”

Misonix interim CEO Stavros Vizirgianakis said: "We're excited to see the significant level of interest surgeons are exhibiting toward our unique platform technologies.”

Misonix is engaged in the development and manufacturing of therapeutic ultrasonic medical devices.

Its ultrasonic medical devices can be used in spine surgery, neurosurgery, orthopedic surgery, wound debridement, cosmetic surgery, laparoscopic surgery, and other surgical and medical applications.